Terns Pharmaceuticals Inc...

NASDAQ: TERN · Real-Time Price · USD
3.83
-0.17 (-4.25%)
At close: Jun 27, 2025, 3:59 PM
3.83
-0.13%
After-hours: Jun 27, 2025, 04:34 PM EDT

Terns Pharmaceuticals Statistics

Share Statistics

Terns Pharmaceuticals has 87.34M shares outstanding. The number of shares has increased by 34.97% in one year.

87.34M
34.97%
2.78%
99.99%
66.42M
809
0.08%

Short Selling Information

The latest short interest is 5.94M, so 6.8% of the outstanding shares have been sold short.

5.94M
6.8%
6.81%
6

Valuation Ratios

The PE ratio is -4.96 and the forward PE ratio is -3.31. Terns Pharmaceuticals's PEG ratio is 0.42.

-4.96
-3.31
0
12.7
1.27
-6.29
0.42
Financial Ratio History

Enterprise Valuation

Currently the Enterprise Value (EV) is not available for Terns Pharmaceuticals.

n/a
n/a
n/a
n/a

Financial Position

The company has a current ratio of 23.14, with a Debt / Equity ratio of 0.

23.14
23.14
0
-0.02
-0.02
0

Financial Efficiency

Return on Equity is n/a and Return on Invested Capital is n/a.

n/a
n/a
n/a
n/a
$-1,505,983.05
59
0
n/a

Taxes

260K
-0.29%

Stock Price Statistics

The stock price has increased by -43.76% in the last 52 weeks. The beta is -0.19, so Terns Pharmaceuticals's price volatility has been lower than the market average.

-0.19
-43.76%
3.3
5.06
55.69
1,010,958

Income Statement

n/a
n/a
-101.87M
-88.85M
-87.7M
-88.59M
-1.12
Full Income Statement

Balance Sheet

The company has 161.44M in cash and 1.35M in debt, giving a net cash position of 160.09M.

161.44M
1.35M
160.09M
-421.48M
339.31M
326.81M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -70.02M and capital expenditures -42K, giving a free cash flow of -70.06M.

-70.02M
-42K
-70.06M
-0.88
Full Cash Flow Statement

Margins

n/a
n/a
n/a
n/a
n/a
n/a
n/a

Dividends & Yields

TERN does not appear to pay any dividends at this time.

n/a
n/a
n/a
n/a
n/a
n/a
Dividend Details

Analyst Forecast

The average price target for TERN is $17.5, which is 356.9% higher than the current price. The consensus rating is "Buy".

$17.5
356.9%
Buy
5
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

n/a
n/a
n/a
n/a

Scores

10.55
2